Search Results 711-720 of 16045 for pharmacogenetics
PROFESSIONAL DETAILS. Primary Appointment. Consultant, Division of Infectious Diseases, Department of Internal Medicine ...
The purpose of this study is to identify known and unknown pathogens and antibodies that can cause severe disease in hospitalized patients. Participation ...
About this study. The purpose of this study is to compare the assessment of the composition of the fecal, nasal,oral and skin microbiota in patients with AD ...
The purpose of this study is to test different doses of PTG-300 to identify a dose that is safe and is possibly effective for reducing the need for phlebotomies ...
About this study. The purpose of this study is to demonstrate whether 4 years of menopausal hormone treatment (MHT) with estrogen initiated at, ...
The Vaccine Research Group at Mayo Clinic provides teaching opportunities to undergraduate, graduate, medical and postdoctoral students.
The secondary aim of this study is to assess the relationship between this digital phenotype and markers of disease severity outcome, including MELD score and ...
Focal dermal hypoplasia (Goltz-Gorlin syndrome). Hemangioma. Hypohidrotic ectodermal dysplasia. Hypomelanosis of Ito. Ichthyosis vulgaris. Keratosis ...
Seifar F, Fox EJ, Shantaraman A, Liu Y, Dammer EB, Modeste E, Duong DM, Yin L, Trautwig AN, Guo Q, Xu K, Ping L, Reddy JS, Allen M, Quicksall Z, Heath L, ...
Gebhart, M.D., M.S., is a fellowship trained Urogynecologist, specializing in Urogynecology and Reconstructive Pelvic Surgery. He is board certified in both ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.